Clinical feasibility of pulmonary vein orifice pacing for the prediction of phrenic nerve injury during cryoballoon ablation of atrial fibrillation.
Action Potentials
Aged
Atrial Fibrillation
/ diagnosis
Cardiac Pacing, Artificial
Cryosurgery
/ adverse effects
Electrophysiologic Techniques, Cardiac
Evoked Potentials, Motor
Feasibility Studies
Female
Heart Rate
Humans
Male
Middle Aged
Peripheral Nerve Injuries
/ diagnosis
Phrenic Nerve
/ injuries
Predictive Value of Tests
Pulmonary Veins
/ physiopathology
Risk Assessment
Risk Factors
Treatment Outcome
atrial fibrillation
compound motor action potential
cryoballoon
phrenic nerve injury
pulmonary vein orifice pacing
Journal
Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
03
03
2019
revised:
08
04
2019
accepted:
29
04
2019
pubmed:
3
5
2019
medline:
29
9
2020
entrez:
3
5
2019
Statut:
ppublish
Résumé
Phrenic nerve (PN) injury is a well-known complication of cryoballoon ablation (CBA) for pulmonary vein (PV) isolation in patients with atrial fibrillation. However, it is still insufficient to practically predict phrenic nerve injury (PNI) before freezing. We hypothesized that phrenic nerve capture (PNC) with phrenic nerve orifice pacing (PVOP) might be a surrogate sign of the close proximity of the PN, and that might predict PNI and changes in the compound motor action potential (CMAP) amplitude. Seventy patients (60 ± 12 years, male 80%, paroxysmal 56%) underwent PVOP with a 20-electrode ring catheter before the CBA. The clinical outcome was the occurrence of transient and persistent PNI. In addition, the PV position and pacing threshold during PNC with PVOP, and changes in the CMAP amplitude were recorded. We compared these measurements between patients with and without PNC (PNC/non-PNC group) with PVOP. PNC with PVOP occurred in 39 (56%) patients and was localized only to the right superior PV. Transient PNI occurred in seven (10%) patients and permanent in none. The CMAP amplitude decreased significantly more in the PNC group (PNC 33% vs non-PNC 16%, P = .027). PNC group had a higher risk of the composite outcome of transient PNI or ≥30% decrease in the CMAP amplitude (PNC 54% vs non-PNC 13%; P < .001). This PVOP technique could be feasible and contribute to predicting transient PNI and CMAP amplitude reductions before cryoapplications. Further studies are necessary to elucidate the additional efficacy of PVOP over CMAP monitoring alone.
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1200-1206Informations de copyright
© 2019 Wiley Periodicals, Inc.